Endocrinology, Vol 137, 4073-4081, Copyright © 1996 by Endocrine Society

ARTICLES

Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line

KH Lin, XG Zhu, HY Shieh, HC Hsu, ST Chen, P McPhie and SY Cheng
Department of Biochemistry, Chang-Guang College of Medicine and Technology, Taoyuan, Taiwan, Republic of China.

To understand the function of thyroid hormone nuclear receptors (TRs) in human hepatocellular carcinoma cells (HCC), we characterized the hormone binding and transactivational activity of TRs in a HCC cell line, J7. TR alpha 1 (J7-TR alpha 1) and TR beta 1 (J7-TR beta 1) complementary DNAs were cloned from this cell line, and the binding activity to the hormone response elements (TREs) and to the thyroid hormone, 3,3',5-triiodo-L-thyronine (T3) of the expressed TR proteins were evaluated. J7-TR alpha 1 and J7-TR beta 1 bound to TREs similarly as the TRs isolated from other tissues. However, J7-TR alpha 1 did not bind to T3, and J7-TR beta 1 bound to T3 with only about 10% the affinity of the wild-type TR beta 1. Sequencing of the complementary DNAs shows a single Met259Ile mutation in J7-TR alpha 1 and Met334Val in J7-TR beta 1. Using reporters containing TREs, we found that J7-TR alpha 1 and J7-TR beta 1 had virtually lost their transactivational activity. Moreover, these two mutants inhibited the transactivational activity of the wild-type TRs by a dominant negative effect not only on the transfected TRs, but also on endogenous TRs in other two HCC cell lines, SK-Hep-1 and HepG2. The potency of the dominant negative effect of these two mutants inversely correlated with the expression level of endogenous TRs. The present studies identified two novel naturally occurring TR mutants that have potent dominant negative action. The identification of both the alpha and beta dominant negative mutants in J7 made this cell line a useful model system to further understand the molecular mechanism of the dominant negative action of TR mutants.

This article has been cited by other articles:

				A. Sanchez-Pacheco, O. Martinez-Iglesias, M. Mendez-Pertuz, and A. Aranda Residues K128, 132, and 134 in the Thyroid Hormone Receptor-{alpha} Are Essential for Receptor Acetylation and Activity Endocrinology, November 1, 2009; 150(11): 5143 - 5152. [Abstract] [Full Text] [PDF]

				R.-N. Chen, Y.-H. Huang, C.-T. Yeh, C.-H. Liao, and K.-H. Lin Thyroid Hormone Receptors Suppress Pituitary Tumor Transforming Gene 1 Activity in Hepatoma Cancer Res., March 15, 2008; 68(6): 1697 - 1706. [Abstract] [Full Text] [PDF]

				P. Maruvada, N. I. Dmitrieva, J. East-Palmer, and P. M. Yen Cell Cycle-dependent Expression of Thyroid Hormone Receptor-{beta} Is a Mechanism for Variable Hormone Sensitivity Mol. Biol. Cell, April 1, 2004; 15(4): 1895 - 1903. [Abstract] [Full Text] [PDF]

				W.-P. Lee, D.-I. Tai, S.-L. Tsai, C.-T. Yeh, Y. Chao, S.-D. Lee, and M.-C. Hung Adenovirus Type 5 E1A Sensitizes Hepatocellular Carcinoma Cells to Gemcitabine Cancer Res., October 1, 2003; 63(19): 6229 - 6236. [Abstract] [Full Text] [PDF]

				S. L. Chen, Y. J. Chang, Y. H. Wu, and K. H. Lin Mitogen-Activated Protein Kinases Potentiate Thyroid Hormone Receptor Transcriptional Activity by Stabilizing Its Protein Endocrinology, April 1, 2003; 144(4): 1407 - 1419. [Abstract] [Full Text] [PDF]

				K.-H. Lin, W.-J. Wang, Y.-H. Wu, and S.-Y. Cheng Activation of Antimetastatic Nm23-H1 Gene Expression by Estrogen and Its {alpha}-Receptor Endocrinology, February 1, 2002; 143(2): 467 - 475. [Abstract] [Full Text] [PDF]

				Y. Kamiya, M. Puzianowska-Kuznicka, P. McPhie, J. Nauman, S.-y. Cheng, and A. Nauman Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma Carcinogenesis, January 1, 2002; 23(1): 25 - 33. [Abstract] [Full Text] [PDF]

				L. D. Miller, K. S. Park, Q. M. Guo, N. W. Alkharouf, R. L. Malek, N. H. Lee, E. T. Liu, and S.-y. Cheng Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation Mol. Cell. Biol., October 1, 2001; 21(19): 6626 - 6639. [Abstract] [Full Text] [PDF]

				P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]

				K.-h. Lin and Y.-h. Wu shen-liang chen Impaired Interaction of Mutant Thyroid Hormone Receptors Associated with Human Hepatocellular Carcinoma with Transcriptional Coregulators Endocrinology, February 1, 2001; 142(2): 653 - 662. [Abstract] [Full Text] [PDF]

				K.-h. Lin, H.-y. Shieh, and H.-C. Hsu Negative Regulation of the Antimetastatic Gene Nm23-H1 by Thyroid Hormone Receptors Endocrinology, July 1, 2000; 141(7): 2540 - 2547. [Abstract] [Full Text] [PDF]

				X.-g. Zhu, K. S. Park, M. Kaneshige, M. K. Bhat, Q. Zhu, C. N. Mariash, P. McPhie, and S.-y. Cheng The Orphan Nuclear Receptor Ear-2 Is a Negative Coregulator for Thyroid Hormone Nuclear Receptor Function Mol. Cell. Biol., April 1, 2000; 20(7): 2604 - 2618. [Abstract] [Full Text]

				X.-G. Zhu, J. A. Hanover, G. L. Hager, and S.-y. Cheng Hormone-induced Translocation of Thyroid Hormone Receptors in Living Cells Visualized Using a Receptor Green Fluorescent Protein Chimera J. Biol. Chem., October 16, 1998; 273(42): 27058 - 27063. [Abstract] [Full Text] [PDF]

				K.-h. Lin, X.-G. Zhu, H.-C. Hsu, S.-L. Chen, H.-y. Shieh, S.-T. Chen, P. McPhie, and S.-y. Cheng Dominant Negative Activity of Mutant Thyroid Hormone {alpha}1 Receptors from Patients with Hepatocellular Carcinoma Endocrinology, December 1, 1997; 138(12): 5308 - 5315. [Abstract] [Full Text] [PDF]

				X.-G. Zhu, P. McPhie, and S.-y. Cheng Differential Sensitivity of Thyroid Hormone Receptor Isoform Homodimers and Mutant Heterodimers to Hormone-Induced Dissociation from Deoxyribonucleic Acid: Its Role in Dominant Negative Action Endocrinology, April 1, 1997; 138(4): 1456 - 1463. [Abstract] [Full Text] [PDF]